Related Experiment Videos
Mortality in siblings of patients coinfected with HIV and hepatitis C virus
Ann-Brit Eg Hansen1, Jan Gerstoft, Gitte Kronborg
1Department of Infectious Diseases, Odense University Hospital, DK-5000 Odense C, Denmark. ann-brit.eg.hansen@rh.hosp.dk
Insights
Hepatitis C virus (HCV) coinfection in human immunodeficiency virus (HIV)-infected patients is linked to increased familial mortality. This suggests shared familial factors, not just HCV, impact survival in HIV patients.
Area of Science:
- Public Health
- Epidemiology
- Genetics
Background:
- Hepatitis C virus (HCV) coinfection is a significant negative prognostic factor for human immunodeficiency virus (HIV)-infected individuals.
- Previous studies indicate increased mortality in HIV/HCV-coinfected patients, but the role of familial factors remains unclear.
Purpose of the Study:
- To investigate whether familial factors contribute to the elevated mortality observed in HIV-infected patients coinfected with HCV.
- To determine if there is an excess familial risk of death associated with HIV/HCV coinfection.
Main Methods:
- A cohort of 3531 Danish HIV-infected patients with HCV testing was analyzed.
- 336,652 matched population controls were identified from the Danish Civil Registration System.
- Siblings of HIV-infected patients (categorized by HCV status) and control subjects were compared for survival after age 20.
Main Results:
- Siblings of HIV/HCV-coinfected patients exhibited substantially higher mortality (MRR 4.23) compared to siblings of controls.
- Siblings of HIV-monoinfected patients also showed increased mortality (MRR 1.43) versus siblings of controls.
- A significant familial excess risk of death was observed in relatives of HIV/HCV-coinfected individuals.
Conclusions:
- HCV infection in HIV-positive individuals serves as a marker for underlying familial factors influencing survival.
- These familial factors appear to impact the survival of HIV-infected patients independently of the direct pathogenicity of HCV.
- The findings highlight the importance of considering familial predispositions in the mortality of HIV/HCV-coinfected patients.
Background:
Coinfection with hepatitis C virus (HCV) is a poor prognostic factor for human immunodeficiency virus (HIV)-infected patients. We examined whether the increased mortality in these patients is partly explained by a familial excess risk of death.
Methods:
Danish HIV-infected patients who had had at least 1 HCV test were included (n=3531). In addition, 336,652 population control subjects matched for sex, age, and residency were identified from the Danish Civil Registration System. For both HIV-infected patients and population control subjects, we identified all siblings born after 1951, with dates of death or emigration. Siblings of HIV-infected patients were classified according to the patients' HCV serostatus. Survival after age 20 years was compared among the groups of siblings.
Results:
We identified 437 siblings of HIV/HCV-coinfected patients, 1856 siblings of HIV-monoinfected patients, and 285,509 siblings of population control subjects. Mortality was substantially higher in siblings of HIV/HCV-coinfected patients than in either siblings of HIV-monoinfected patients (mortality rate ratio [MRR], 2.97 [95% confidence interval {CI}, 1.98-4.45]) or siblings of control subjects (MRR, 4.23 [95% CI, 3.09-5.79]). Siblings of HIV-monoinfected patients had slightly higher mortality (MRR, 1.43 [95% CI, 1.10-1.85]) than siblings of control subjects.
Conclusions:
HCV infection is a marker of familial factors that affect the survival of HIV-infected patients independently of the pathogenicity of HCV.
Related Concept Videos
Hepatitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles
Cryptococcal Meningitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease